Trending
- Optimizing Surveillance Protocols After Focal Therapy for Prostate Cancer
- RASolute 302 and the Future of Pancreatic Cancer Treatment: Paul Oberstein, MD, on the KRAS Breakthrough
- Defining New Thresholds for Precisely Mitigating CAR T Toxicity
- DTX3 promotes anti-tumor immunity by inducing PD-L1 ubiquitination and is suppressed by p65/miR-222 in bladder cancer
- Reviewing the CheckMate 9DW Trial of Nivolumab Plus Ipilimumab in Unresectable HCC
- How to Speak With Patients About Potential Changes to Care During Biopsy Needle Delays
- Novel Agent Begins STARLIGHT-1 Dose Expansion in Relapsed/Refractory B-Cell NHL
- Consolidative Radiotherapy Adds Toxicity Without Survival Benefit in SCLC
